INS and type 2 diabetes mellitus: Aim To evaluate the effectiveness of insulin degludec in managing T2DM in patients with CLD based on changes in glycated hemoglobin (HbA1c), fasting plasma glucose, and postprandial glucose (PPG) levels, and to evaluate its safety, based on the incidence of hypoglycemic events.